55 related articles for article (PubMed ID: 22302889)
1. Some behavioural and neurochemical effects of ipsapirone in two rodent models of depression.
McNamara MG; Kelly JP; Leonard BE
J Psychopharmacol; 1996 Jan; 10(2):126-33. PubMed ID: 22302889
[TBL] [Abstract][Full Text] [Related]
2. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression.
Harkin A; Kelly JP; McNamara M; Connor TJ; Dredge K; Redmond A; Leonard BE
Eur J Pharmacol; 1999 Jan; 364(2-3):123-32. PubMed ID: 9932714
[TBL] [Abstract][Full Text] [Related]
3. Effects of chronic desipramine on waiting behaviour for a food reward in olfactory bulbectomized rats.
Kelly JP; Leonard BE
J Psychopharmacol; 1996 Jan; 10(2):153-6. PubMed ID: 22302893
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models.
Ramamoorthy R; Radhakrishnan M; Borah M
Behav Pharmacol; 2008 Feb; 19(1):29-40. PubMed ID: 18195592
[TBL] [Abstract][Full Text] [Related]
5. Behavioural and neurochemical effects of dizocilpine in the olfactory bulbectomized rat model of depression.
Redmond AM; Kelly JP; Leonard BE
Pharmacol Biochem Behav; 1997 Oct; 58(2):355-9. PubMed ID: 9300592
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
7. Olfactory bulbectomy provokes a suppression of interleukin-1beta and tumour necrosis factor-alpha production in response to an in vivo challenge with lipopolysaccharide: effect of chronic desipramine treatment.
Connor TJ; Harkin A; Kelly JP; Leonard BE
Neuroimmunomodulation; 2000; 7(1):27-35. PubMed ID: 10601816
[TBL] [Abstract][Full Text] [Related]
8. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats.
Xu Y; Ku BS; Yao HY; Lin YH; Ma X; Zhang YH; Li XJ
Pharmacol Biochem Behav; 2005 Sep; 82(1):200-6. PubMed ID: 16171853
[TBL] [Abstract][Full Text] [Related]
10. The effect of tianeptine and sertraline in three animal models of depression.
Kelly JP; Leonard BE
Neuropharmacology; 1994 Aug; 33(8):1011-6. PubMed ID: 7531300
[TBL] [Abstract][Full Text] [Related]
11. Neuroanatomical basis for the antidepressant-like effects of the 5-HT(1A) receptor agonists 8-OH-DPAT and ipsapirone in the rat forced swimming test.
Schreiber R; De Vry J
Behav Pharmacol; 1993 Dec; 4(6):625-636. PubMed ID: 11224231
[TBL] [Abstract][Full Text] [Related]
12. Effects of 8-OH-DPAT and ipsapirone in the tests used for evaluation of the antidepressant action.
Tatarczyńska E; Chojnacka-Wójcik E
Pol J Pharmacol Pharm; 1989; 41(4):321-30. PubMed ID: 2534521
[TBL] [Abstract][Full Text] [Related]
13. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
14. Metyrapone displays antidepressant-like properties in preclinical paradigms.
Healy DG; Harkin A; Cryan JF; Kelly JP; Leonard BE
Psychopharmacology (Berl); 1999 Aug; 145(3):303-8. PubMed ID: 10494579
[TBL] [Abstract][Full Text] [Related]
15. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
[TBL] [Abstract][Full Text] [Related]
16. The effects of central administration of neuropeptide Y on behavior, neurotransmitter, and immune functions in the olfactory bulbectomized rat model of depression.
Song C; Earley B; Leonard BE
Brain Behav Immun; 1996 Mar; 10(1):1-16. PubMed ID: 8735565
[TBL] [Abstract][Full Text] [Related]
17. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
Jolas T; Haj-Dahmane S; Kidd EJ; Langlois X; Lanfumey L; Fattaccini CM; Vantalon V; Laporte AM; Adrien J; Gozlan H
J Pharmacol Exp Ther; 1994 Mar; 268(3):1432-43. PubMed ID: 8138956
[TBL] [Abstract][Full Text] [Related]
18. Tiagabine treatment is associated with neurochemical, immune and behavioural alterations in the olfactory bulbectomized rat model of depression.
Pistovcakova J; Dostalek M; Sulcova A; Jezova D
Pharmacopsychiatry; 2008 Mar; 41(2):54-9. PubMed ID: 18311685
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivity.
Foreman MM; Fuller RW; Rasmussen K; Nelson DL; Calligaro DO; Zhang L; Barrett JE; Booher RN; Paget CJ; Flaugh ME
J Pharmacol Exp Ther; 1994 Sep; 270(3):1270-81. PubMed ID: 7523657
[TBL] [Abstract][Full Text] [Related]
20. Chronic buspirone treatment normalizes open field behavior in olfactory bulbectomized rats: assessment with a quantitative autoradiographic evaluation of the 5-HT1A binding sites.
Sato H; Skelin I; Debonnel G; Diksic M
Brain Res Bull; 2008 Mar; 75(5):545-55. PubMed ID: 18355630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
